Wednesday, February 10, 2021 1PM (PST) Recording Coming Soon.
“Engineering more effective cancer immunotherapies via drug delivery technologies”
Darrell Irvine, Ph.D.
Professor, Departments of Biological Engineering and Materials Science & Engineering
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Ragon Institute of MGH, MIT, and Harvard
Investigator, Howard Hughes Medical Institute
Dr. Irvine obtained an Honors Bachelor’s degree in Engineering Physics from the University of Pittsburgh. As a National Science Foundation graduate fellow he then studied Polymer Science at the Massachusetts Institute of Technology. Following completion of his Ph.D., he was a Damon Runyon-Walter Winchell postdoctoral fellow in immunology at the Beckman Center for Molecular and Genetic Medicine. He is presently a Professor at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute. He is also an Associate Director for the Koch Institute for Integrative Cancer Research at MIT and serves on the steering committee of the Ragon Institute of MGH, MIT, and Harvard.